London, UK, and Durham (NC), US – February 13th, 2025: Phastar, a global specialist biometrics & data science contract research organization (CRO), won a Best of Show Award at Summit for Clinical Ops Executives (SCOPE) US 2025.
Having taken place in Orlando, Florida from the 3rd-6th February, SCOPE’s 300+ attendees voted on more than 60 product finalists to declare Phastar’s Clinical Intelligence Platform as the winner. By leveraging data visualizations and analytics, Phastar’s award winning Clinical Intelligence Platform provides sponsors with near real-time access to information and offers user-friendly tools for deep data understanding and rapid anomaly resolution.
A new addition to the platform is an RBQM app. The tool supports critical RBQM processes like Risk Assessment, Central Monitoring, Issue Management, Risk Reassessment, Targeted Site Monitoring, and KRI Tracking, while ensuring regulatory compliance and enabling continuous, data-driven improvements throughout the clinical trial. A key feature is the ability to assign risk scores to different clinical sites or activities based on predefined criteria, enabling effective prioritization of site visits.
Also newly added, is the Recruitment Forecasting app, which uses advanced statistical modelling to predict participant progression and treatment administration timelines, accounting for late site openings and real-time data updates.
Graham Clark, CEO at Phastar, commented: “We are delighted to have been honored with the SCOPE Best in Show award, recognizing our Clinical Intelligence Platform for its ability to maximize the value of data for our clients. Our platform ensures that data is accessible, consumable, and actionable in real time, empowering users with intuitive insights. SCOPE provided a fantastic opportunity to showcase how we are leveraging new technologies alongside advanced statistical and data analysis expertise to accelerate drug development. It also served as an invaluable space to connect with other industry innovators who share our vision for the future of clinical research.”
About Phastar
Phastar is an award winning, global, specialist biometrics & data science contract research organization offering leading data management, data science, statistical consulting, and clinical trial reporting services by providing expert consultants and managing and delivering in-house projects, FSP-style arrangements, and preferred partnerships. Phastar currently has 15 offices worldwide with plans to open additional locations in the future to serve prospective and existing clients. Our number one priority is ensuring on time, quality work: every project undertaken is supervised on methodology and utilizes internal processes designed to guarantee optimal quality, inspired by 4,000 years accumulated technical experience across the company.
Media contact:
Sophie Beattie – Discovery PR, on behalf of Phastar
Email: sophie@discovery-pr.com
Mobile: +44 (0)7494 129339
Office: +44 (0)1606 889194
